Simple Summary Thymic carcinoma is identified as thoracic neoplasm having low sensitivity
to systemic chemotherapy. As first-line setting, platinum-based chemotherapy is …

Background Thymic carcinoma, a relatively rare entity, often presents as locally advanced
disease, and sometimes as distant metastatic disease. The treatment strategy, long-term …

Background Because of the rarity of thymic epithelial tumors (TETs), there is no treatment for
managing unresectable tumors that is supported by a high level of evidence. We present …

Thymic carcinoma (TC) is thymic epithelial tumor which differs from thymoma because of its
rarity, agressiveness and poor prognosis. We studied nine patients with TC according to the …

Thymic carcinoma is a rare epithelial tumor of the thymus with a poor prognosis, and
multimodal approaches are important for its treatment. Recently, a number of studies have …

Thymic epithelial tumours (TETs) are rare tumours originating from the thymus. Considering
the rarity of this disease, the management of TETs is still challenging and difficult. In fact, all …

Introduction Thymic carcinoma (TC) is an exceptionally rare form of tumor that differs from
thymoma by virtue of its very poor prognosis. The difficulties associated with conducting …

Thymic neoplasms are rare malignant tumours, for which the mainstay of treatment is
surgical resection. Platinum-based chemotherapy remains the principal treatment in …

Thymic carcinoma encompasses a diverse group of rare tumors that occur almost
exclusively in the prevascular (anterior) mediastinum. Thymic carcinomas have a worse …

Background Thymic carcinoma is a type of rare and highly malignant tumor. Limited
information was available on prognostic factors of late-stage thymic carcinoma. The aim of …